Metformin - Shiner PharmAlternative Names: HENFORMIN F.C.
Latest Information Update: 12 Feb 2016
Price : *
At a glance
- Originator Shiner Pharm Corp
- Class Antihyperglycaemics; Biguanides; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diabetes mellitus
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 12 Feb 2016 Launched for Diabetes mellitus in Taiwan (PO) before February 2016